BackgroundCheck.run
Search For

Keith William Hildebrand, 6511913 Knippwood Ln, Houston, TX 77024

Known as:
Keith W Hildebrand Keith W Hidebrand Ketih W Hildebrand Keith D
Related to:
Timothy Moseley 68 Kara Hildebrand Dana Y 60

Keith Hildebrand Phones & Addresses

11913 Knippwood Ln, Houston, TX 77024    713-9739958   

1007 Memorial Village Dr, Houston, TX 77024    713-9739958   

Austin, TX   

7310 Emerald Glen Ct, Sugar Land, TX 77479    281-5459762   

Tulsa, OK   

Minneapolis, MN   

Morris Plains, NJ   

Cedar Park, TX   

Greenwood Village, CO   

5116 Eagle Trace Trl, Austin, TX 78730   

Work

Position: Protective Service Occupations

Education

Degree: Associate degree or higher
Get Report
Control this profile

Mentions for Keith William Hildebrand

Keith Hildebrand resumes & CV records

Resumes

Keith Hildebrand Photo 27

Owner

Location:
Austin, TX
Industry:
Construction
Work:
Outstanding
Owner
Keith Hildebrand Photo 28

Keith Hildebrand

Keith Hildebrand Photo 29

Keith Hildebrand

Keith Hildebrand Photo 30

Keith Hildebrand

Keith Hildebrand Photo 31

Keith Hildebrand

Publications & IP owners

Us Patents

Baclofen Formulation In A Polyorthoester Carrier

US Patent:
8475823, Jul 2, 2013
Filed:
Apr 17, 2009
Appl. No.:
12/426021
Inventors:
Christopher M. Hobot - Tonka Bay MN, US
Michael E. Benz - Ramsey MN, US
Keith R. Hildebrand - Houlton WI, US
Bryant J. Pudil - Plymouth MN, US
Assignee:
Medtronic, Inc. - Minneapolis MN
International Classification:
A61F 2/04
A61K 9/14
A01N 37/12
US Classification:
424423, 424486, 514567
Abstract:
Effective treatments of pain for extended periods of time are provided. The treatments include the administration of one or more drug depots intraspinally wherein the drug depots include an effective amount of baclofen formulated within a polyorthoester. By administration of one or more drug depots, one can relieve pain caused by diverse sources, including but not limited to chronic pelvic pain syndromes, spinal disc herniation (i. e. sciatica), spondilothesis, stenosis, discongenic back pain and joint pain, as well as pain that is incidental to surgery. In some embodiments, the relief can be for at least thirty days, at least sixty days, at least one hundred days or at least one hundred and thirty-five days.

Bupivacaine Formulation In A Polyorthoester Carrier

US Patent:
2009020, Aug 13, 2009
Filed:
Apr 17, 2009
Appl. No.:
12/426005
Inventors:
Christopher M. Hobot - Tonka Bay MN, US
Michael E. Benz - Ramsey MN, US
Keith R. Hildebrand - Houlton WI, US
Bryant J. Pudil - Plymouth MN, US
Assignee:
Medtronic, Inc. - Minneapolis MN
International Classification:
A61K 51/06
A61L 31/16
A61P 29/00
A61K 31/445
US Classification:
424 165, 424426, 514330
Abstract:
Effective treatments of pain, such as chronic pelvic pain, for extended periods of time are provided. The treatments include the administration of one or more drug depots intraspinally wherein the drug depots include an effective amount of bupivacaine formulated within a polyorthoester. By administration of one or more drug depots, one can relieve pain caused by diverse sources, including but not limited to chronic pelvic pain syndromes, spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discongenic back pain and joint pain, as well as pain that is incidental to surgery. In some embodiments, the relief can be for at least thirty days, at least sixty days, at least one hundred days or at least one hundred and thirty-five days.

Benzodiazepine Formulation In A Polyorthoester Carrier

US Patent:
2009020, Aug 13, 2009
Filed:
Apr 17, 2009
Appl. No.:
12/426031
Inventors:
Christopher M. Hobot - Tonka Bay MN, US
Michael E. Benz - Ramsey MN, US
Keith R. Hildebrand - Houlton WI, US
Bryant J. Pudil - Plymouth MN, US
Assignee:
Medtronic, Inc. - Minneapolis MN
International Classification:
A61F 13/00
A61K 31/551
US Classification:
424422, 514220
Abstract:
Effective treatments of pain for extended periods of time are provided. The treatments include the administration of one or more drug depots intraspinally wherein the drug depots include an effective amount of a benzodiazepine, such as midazolam, formulated within a polyorthoester. By administration of one or more drug depots, one can relieve pain caused by diverse sources, including but not limited to chronic pelvic pain syndromes, spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discongenic back pain and joint pain, as well as pain that is incidental to surgery. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days or at least one hundred and thirty-five days.

Clonidine Formulation In A Polyorthoester Carrier

US Patent:
2009026, Oct 22, 2009
Filed:
Mar 26, 2009
Appl. No.:
12/412024
Inventors:
Christopher M. Hobot - Tonka Bay MN, US
Phillip E. McDonald - Plymouth MN, US
Keith R. Hildebrand - Houlton WI, US
Assignee:
WARSAW ORTHOPEDIC, INC. - Warsaw IN
International Classification:
A61K 9/00
US Classification:
424423
Abstract:
Effective treatments of acute pain for extended periods of time are provided. The treatments include the administration of one or more drug depots at or near a target site wherein the drug depots include an effective amount of clonidine formulated within a polyorthoester. By administration of one or more drug depots at or near the target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discongenic back pain and joint pain, as well as pain that is incidental to surgery. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days or at least one hundred and thirty-five days.

Simultaneous Cardiac Pacing And Local Drug Delivery Method

US Patent:
5634899, Jun 3, 1997
Filed:
Jan 4, 1994
Appl. No.:
8/177175
Inventors:
James E. Shapland - Shoreview MN
Keith R. Hildebrand - Houlton WI
Assignee:
CorTrak Medical, Inc. - Minneapolis MN
International Classification:
A61M 3100
US Classification:
604 51
Abstract:
An apparatus and method for delivering a drug selectively and locally to internal body tissue with a catheter using electric current/voltage controlled in conjunction with active pacing of cardiac activity.

Porous Balloon For Selective Dilatation And Drug Delivery

US Patent:
5458568, Oct 17, 1995
Filed:
Sep 17, 1993
Appl. No.:
8/123374
Inventors:
Joel R. Racchini - Edina MN
James E. Shapland - Shoreview MN
Mark B. Knudson - Shoreview MN
Jin Shimada - Falcon Heights MN
Keith R. Hildebrand - Houlton WI
Assignee:
CorTrak Medical, Inc. - Minneapolis MN
International Classification:
A61N 130
US Classification:
604 19
Abstract:
A drug delivery apparatus and method for delivering a drug locally to internal body tissue. The invention contemplates positioning a drug delivery device in a body passageway or within body tissue and then selectively wetting a membrane within the device, making the membrane permeable and allowing transport of a drug across the membrane and into the passageway wall or body tissue.

Simultaneous Cardiac Pacing And Local Drug Delivery

US Patent:
5865787, Feb 2, 1999
Filed:
Sep 13, 1996
Appl. No.:
8/710146
Inventors:
James E. Shapland - Shoreview MN
Keith R. Hildebrand - Houlton WI
Assignee:
Cortrak Medical, Inc. - St. Paul MN
International Classification:
A61N 130
US Classification:
604 21
Abstract:
An apparatus and method for delivering a drug selectively and locally to internal body tissue with a catheter using electric current/voltage controlled in conjunction with active pacing of cardiac activity.

Drug Delivery Apparatus And Method

US Patent:
5282785, Feb 1, 1994
Filed:
Oct 5, 1992
Appl. No.:
7/956789
Inventors:
James E. Shapland - Shoreview MN
Mark B. Knudson - Shoreview MN
Jin Shimada - Falcon Heights MN
Keith R. Hildebrand - Houlton WI
Assignee:
CorTrak Medical, Inc. - Roseville MN
International Classification:
A61B 1736
US Classification:
604 21
Abstract:
A drug delivery apparatus and method for delivering a drug locally to internal body tissue. The invention contemplates positioning a drug delivery device in a body passageway or within body tissue and then selectively introducing a selected drug so that it is transported across a drug transport wall of the device for direct contact with the passageway wall or body tissue. A further aspect of the present invention involves treating a dilated vessel in the area of a stenotic lesion with a fixative or other drug to render the vessel biologically inert and to form a biological stent or prevent restenosis using specifically selected drugs. A still further aspect of the present invention involves treating a tumor or local or regional tissue mass with antitumor sensitizing agents, biological modifiers, antibiotics or other types of drugs by delivery of the drug to the tumor or tissue area directly or through the passageway wall.

Possible Relatives

Cynthia M Hildebrand  David Hildebrand  Dale F Hildebrand  Deborah Hildebrand  Debra A Hildebrand  Daniel K Hildebrand  Aaron M Hildebrand  Keith A Johnson  Keith J Standish  Keith E Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.